To evaluate the properties of the QHRS Biopyramid in relation to the harmonization of the biological effects of electromagnetic radiation and biogeological fields with a harmful effect on the human body.
1. Problem setting.
2. Research and analysis of the protective effect of the QHRS biopyramid against the biological impact of electromagnetic radiation and geobiological fields with a harmful effect on the human body using the bio-fitback method in anonymous research.
2.1. Selection of respondents.
2.1.1. Division of respondents into main and control groups.
2.2. The principle of measuring the frequency of fields with a harmful effect on the human body.
2.2.1. Measurement log in the main group.
2.2.2. Record of measurements in the control group.
3. Biological measurement with the bio-fitback process.
3.1. Explanation of the principles of the bio-fitback process.
3.2. Measuring devices and sensors.
3.2.1. EDA sensor.
3.2.2. BVP sensor.
3.2.3. Temperature sensor.
3.3. Selection of measurement procedures.
3.4. Basic explanation of report charts.
4. Rezime of statistical results.
4.1. Tabular presentation of measured values of skin conductivity.
4.1.1. Measurement values of skin conductivity in the main group (µSiemens).
4.1.2. Measured values of skin conductivity in the control group (µSiemens).
4.1.3. Graphic representation of the development of the mean value of skin conductivity in the main and control grupi.
4.2. Table presentation of measured skin temperature values.
4.2.1. Measurement values of skin temperature in the main group ( ºC).
4.2.2. Measurement values of skin temperature in the control group ( ºC).
4.2.3. Graphic representation of the development of the mean value of the skin temperature of the subjects in the main and control groups.
4.3. Tabular display of heart rate measurement data.
4.3.1. Heart rate measurements in the main group (beats per minute).
4.3.2. Measurement values of heart beats in the control group (beats per minute).
4.3.3. Graphic representation of the mean value of heart beats in subjects in the main and control groups.
4.3.3.1. Development of heartbeats by type of reactionja
4.3.3.2. Development of heartbeats by reaction type (80 beats per minute).
4.4. Tabular display of measurement data of the required amount of blood.
4.4.1. Measuring values of the required amount of blood in the main group.
4.4.2. Measurement values of the required amount of blood in the control group.
4.4.3. Graphic presentation of the development of the mean value of the required amount of blood in subjects in the main and control groups.
4.5. Development of heart rate variability.
4.5.1. Criteria for measured values of heart rate variability in the main group.
4.5.2. Criteria for measured values of heart rate variability in the control group.
4.5.3. Graphic representation of the development of the mean length of heart beats in subjects in the main and control groups.
4.5.4. Graphic representation of the development of the overall effect on the vegetative nervous system in subjects in the main and control groups.
4.5.5. Graphic representation of the reduction in the number of consecutive pairs of heartbeats that showed a difference of more than 50 ms.
5. Detailed overview of the records of the measurements of subjects in the main and control groups.
5.1. Preliminary notes.
5.2. Comparisonding the results of measurements in male subjects in the main and control groups.
5.3. Comparison of measurement results in female subjects in the main and control group.
6. Discussion.
The headquarters of the company is in Birmingham/Great Britain. Commercial Register of England and Wales no. 5521855
IGEF Certificates: Apartado 96, E-38370 La Matanza, Tenerife, Spain; N.I.E.H-6128987
Head: B.Sc. Wolf Dietrich Rose - tel. 0034-922 57 36 37; fax 0034-92257 3637
Information and contact on the Internet: www.elektrosmog.com e-mail : info@eletrosmog.com

